DUAN An-hu, ZHANG Wei, BAI Yin-lan, KANG Jian, WANG Rui,XU Zhi-kai, WANG Li-mei. Construction and immunogenicity of the DNA vaccine of dormancy related antigen Rv1733c of Mycobacterium tuberculosis[J]. Chinese Journal of Antituberculosis, 2013, 35(9): 679-685.
[1]World Health Organization. Tuberculosis[EB/OL]. Geneva:WHO,2013[2013-04-18]. http://www.who.int/mediacentre/factsheets/fs104/en/index.html.[2]Voskuil MI. Mycobacterium tuberculosis gene expression during environmental conditions associated with latency. Tuberculosis (Edinb),2004,84(3/4):138-143.[3]Muttucumaru DG,Roberts G,Hinds J,et al. Gene expression profile of Mycobacterium tuberculosis in a non-replicating state. Tuberculosis (Edinb),2004, 84(3/4):239-246.[4]Leyten EM,Lin MY,Franken KL,et al. Human T-cell responses to 25 novel antigens encoded by genes of the dormancy regulon of Mycobacterium tuberculosis. Microbes Infect,2006, 8(8):2052-2060.[5]Lin MY,Geluk A,Smith SG,et al. Lack of immune responses to Mycobacterium tuberculosis DosR regulon proteins following Mycobacterium bovis BCG vaccination. Infect Immun,2007,75(7):3523-3530.[6]Black GF, Thiel BA, Ota MO,et al. Immunogenicity of novel DosR regulon-encoded candidate antigens of Mycobacterium tuberculosis in three high-burden populations in Africa. Clin Vaccine Immunol,2009,16(8):1203-1212.[7]张薇,柏银兰,康健,等.结核分枝杆菌持续感染期抗原Rv1733c的表达、纯化和鉴定. 现代生物医学进展,2012,12(10):1868-1871.[8]吴雪琼.新型结核病疫苗的研究现状与发展趋势.中国防痨杂志,2012,34(3):133-137.[9]Huygen K. On the use of DNA vaccines for the prophylaxis of Mycobacterial diseases.Infect Immun,2003,71(4):1613-1621.[10]Roupie V,Romano M,Zhang L. Immunogenicity of eight dormancy regulon-encoded proteins of Mycobacterium tuberculosis in DNA-vaccinated and tuberculosis-infected mice. Infect Immun,2007,75 (2):941-949.[11]Bivas-Benita M, Lin MY, Bal SM,et al. Pulmonary delivery of DNA encoding Mycobacterium tuberculosis latency antigen Rv1733c associated to PLGA-PEI nanoparticles enhances T cell responses in a DNA prime/protein boost vaccination regimen in mice. Vaccine,2009,27(30):4010-4017.